This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Conceptus(R) Reports Fourth Quarter Financial Results And Introduces 2013 Financial Guidance

Twelve Month Highlights

  • Total sales for the twelve months ended December 31, 2012 reached $140.7 million, representing an increase of 10.8%. U.S. sales were $109.1 million, representing 13.1% growth. Essure domestic sales increased 14.4%.  International sales were $31.6 million, representing growth of 3.6%.  On a constant-currency basis, international growth for 2012 was approximately 10.8%.  
  • Gross profit was 83.3% of net sales in 2012, compared with 82.2% of net sales for 2011.  
  • Operating expenses were $103.9 million, compared with $107.5 million for 2011. This decrease reflects a reduction in severance costs associated with the company's former CEO, lower domestic sales headcount, and lower legal fees partially offset by increased expenses for domestic consumer marketing, and costs related to product development of the next-generation Essure device and clinical trials for the Essure TVU confirmation study.  
  • Net income for 2012 was $5.4 million, or $0.16 per fully diluted share, compared with a net loss for 2011 of $7.9 million, or ($0.25) per share. Adjusted EBITDA for 2012 was $28.2 million, an increase of 100.0% compared with adjusted EBITDA for 2011 of $14.1 million.

2013 Financial Guidance

Conceptus introduces its 2013 financial guidance as follows:

  • Sales: the Company expects 2013 sales to be in the range of $155 million to $159 million. This represents a growth of 10% to 13% over sales in 2012.  
  • Adjusted EBITDA: the Company expects 2013 adjusted EBITDA to be in the range of $34 million to $37 million. This represents a growth of 21% to 31% over adjusted EBITDA in 2012.

"We are excited about 2013, and our guidance reflects our anticipation that we will complete the execution improvements in our commercial operations started last year. In addition, our business may benefit from several important tailwinds this year, and we hope to position ourselves to take full advantage of the favorable environment," commented Mr. Grossman.

2 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs